RYAM SVP granted 4,113 performance-based shares

Rayonier Advanced Materials SVP, Biomaterials Christian Antoine Lucien Ribeyrolle acquired 4,113 shares of common stock through a stock award.

Rhea-AI Filing Summary

Rayonier Advanced Materials SVP, Biomaterials Christian Antoine Lucien Ribeyrolle acquired 4,113 shares of common stock through a stock award. The shares were issued at no cash cost following the vesting and settlement of performance share units granted on March 1, 2023.

The performance share units vested after a three-year performance period ending February 27, 2026, based on relative and absolute total shareholder return and cumulative adjusted EBITDA. After this grant, Ribeyrolle directly owns a total of 51,477 common shares.

Insider Trade Summary

Grant/Award: 4,113 shares

Grant/Award 1 txn

Insider Ribeyrolle Christian Antoine Lucien

Role SVP, Biomaterials

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,113	$0.00	$0.00

Holdings After Transaction: Common Stock — 51,477 shares (Direct)

Footnotes (2)

1. F1. Represents shares of common stock issued upon the vesting and settlement of Performance Share Units ("PSUs"). The PSUs were originally granted on March 1, 2023 and were subject to performance-based vesting over a three-year performance period ending February 27, 2026, based on (i) relative and absolute Total Shareholder Return ("TSR") metrics and (ii) cumulative adjusted EBITDA performance. On March 3, 2026, the Compensation and Management Development Committee certified the level of achievement of the applicable performance criteria, which certification triggered vesting of the award. The number of shares reported reflects the PSUs earned based on such certified performance results.
2. F2. PSUs convert into common stock on a one-for-one basis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did RYAM executive Christian Ribeyrolle report on this Form 4?

Christian Ribeyrolle reported acquiring 4,113 shares of Rayonier Advanced Materials common stock. The shares were issued at no cash cost upon vesting of performance share units tied to multi-year performance, increasing his direct ownership to 51,477 shares following the transaction.

How did Christian Ribeyrolle of RYAM acquire the 4,113 common shares?

The 4,113 Rayonier Advanced Materials shares were issued upon vesting and settlement of performance share units. These units were granted in 2023 and converted into common stock on a one-for-one basis after performance goals were certified by the compensation committee.

What performance period applied to the RYAM performance share units that vested for Ribeyrolle?

The performance share units had a three-year performance period ending February 27, 2026. Vesting depended on relative and absolute total shareholder return and cumulative adjusted EBITDA, with the compensation committee certifying results on March 3, 2026 before shares were delivered.

What is Christian Ribeyrolle’s direct RYAM share ownership after this Form 4 transaction?

After this award, Christian Ribeyrolle directly owns 51,477 Rayonier Advanced Materials common shares. This total reflects the addition of 4,113 shares issued upon vesting of performance share units that were originally granted on March 1, 2023 based on performance criteria.

Were cash proceeds involved in the RYAM Form 4 transaction for Christian Ribeyrolle?

No cash proceeds were involved in this transaction. The 4,113 Rayonier Advanced Materials shares were issued at a reported price of $0.0000 per share, representing a grant and settlement of performance share units rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/05/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ribeyrolle Christian Antoine Lucien

(Last) (First) (Middle)

1301 RIVERPLACE BOULEVARD

SUITE 2300

(Street)

JACKSONVILLE FL 32207

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RAYONIER ADVANCED MATERIALS INC. [ RYAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Biomaterials

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/03/2026		A		4,113(1)	A	$0.0000(2)	51,477	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock issued upon the vesting and settlement of Performance Share Units ("PSUs"). The PSUs were originally granted on March 1, 2023 and were subject to performance-based vesting over a three-year performance period ending February 27, 2026, based on (i) relative and absolute Total Shareholder Return ("TSR") metrics and (ii) cumulative adjusted EBITDA performance. On March 3, 2026, the Compensation and Management Development Committee certified the level of achievement of the applicable performance criteria, which certification triggered vesting of the award. The number of shares reported reflects the PSUs earned based on such certified performance results.

2. PSUs convert into common stock on a one-for-one basis.

	Brenda K. Davis, Attorney-in-Fact	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.